Renal function and metabolic syndrome components on cardiovascular and all-cause mortality

Atherosclerosis

Volumn 197, Issue 2, 2008, Pages 860-867

  Chien, Kuo Liong ^a,b   Hsu, Hsiu Ching ^b   Lee, Yuan Teh ^b,c   Chen, Ming Fong ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c Ming Shen Medical Center   (Taiwan)

Author keywords

Cardiovascular death; Chinese; Metabolic syndrome; Renal function

Indexed keywords

CREATININE; URIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINESE; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; URIC ACID BLOOD LEVEL;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHINA; CREATININE; DATABASES, FACTUAL; FEMALE; GLOMERULAR FILTRATION RATE; HEALTH SURVEYS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RISK FACTORS; ROC CURVE;

EID: 41249086784     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.07.037     Document Type: Article

References (27)

1. Grundy S.M. Point: the metabolic syndrome still lives. Clin Chem 51 (2005) 1352-1354
2. McNeill A.M., Rosamond W.D., Girman C.J., et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28 (2005) 385-390
3. Muntner P., He J., Hamm L., Loria C., and Whelton P.K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13 (2002) 745-753
4. Fried L.F., Shlipak M.G., Crump C., et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41 (2003) 1364-1372
5. McAlister F.A., Ezekowitz J., Tonelli M., and Armstrong P.W. Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study 2. Circulation 109 (2004) 1004-1009
6. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
7. Kurella M., Lo J.C., and Chertow G.M. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 16 (2005) 2134-2140
8. Gomez P., Ruilope L.M., Barrios V., et al. Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: the FATH study. J Am Soc Nephrol 17 (2006) S194-S200
9. Chien K.L., Yang C.Y., and Lee Y.T. Major gene effects in systolic and diastolic blood pressure in the families receiving health examination in Taiwan. J Hypertens 21 (2003) 1-7
10. Lopes-Virella M., Stone P., Ellis S., and Colwell J.A. Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem 23 (1977) 882-884
11. de Jong P.E., and Gansevoort R.T. Screening techniques for detecting chronic kidney disease. Curr Opin Nephrol Hypertens 14 (2005) 567-572
12. Rule A.D., Larson T.S., Bergstralh E.J., et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141 (2004) 929-937
13. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
14. Tan C.E., Ma S., Wai D., Chew S.K., and Tai E.S. Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?. Diabetes Care 27 (2004) 1182-1186
15. Hanley J.A., and McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143 (1982) 29-36
16. McCullough P.A. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?. J Am Coll Cardiol 41 (2003) 725-728
17. Lastra G., Manrique C., and Sowers J.R. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv Chronic Kidney Dis 13 (2006) 365-373
18. Irie F., Iso H., Sairenchi T., et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int 69 (2006) 1264-1271
19. Hsu C.C., Hwang S.J., Wen C.P., et al. High prevalence and low awareness of CKD in Taiwan: a study on the relationship between serum creatinine and awareness from a nationally representative survey. Am J Kidney Dis 48 (2006) 727-738
20. Kahn R., Buse J., Ferrannini E., and Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28 (2005) 2289-2304
21. Nakanishi N., Okamoto M., Yoshida H., et al. Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers. Eur J Epidemiol 18 (2003) 523-530
22. Taniguchi Y., Hayashi T., Tsumura K., et al. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: The Osaka Health Survey. J Hypertens 19 (2001) 1209-1215
23. Chien K.L., Hsu H.C., Sung F.C., et al. Hyperuricemia as a risk factor on cardiovascular events in Taiwan: The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 183 (2005) 147-155
24. Hansel B., Giral P., Nobecourt E., et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 89 (2004) 4963-4971
25. Johnson R.J., Kang D.H., Feig D., et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension 41 (2003) 1183-1190
26. Feig D.I., Mazzali M., Kang D.H., et al. Serum uric acid: a risk factor and a target for treatment?. J Am Soc Nephrol 17 (2006) S69-S73
27. Quinones Galvan A., Natali A., Baldi S., et al. Effect of insulin on uric acid excretion in humans. Am J Physiol 268 (1995) E1-E5